trending Market Intelligence /marketintelligence/en/news-insights/trending/k-jmjygqppjgxhnsrlcplw2 content esgSubNav
In This List

Kane Biotech adds board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Kane Biotech adds board member

Kane Biotech Inc. appointed Rashieda Gluck to its board.

Gluck is Aurinia Pharmaceuticals Inc.'s senior vice president of global clinical operations.

Winnipeg, Manitoba-based Kane Biotech develops technologies and products that prevent and remove microbial biofilms.